EC
CLVS

EcoR1 Capital’s Clovis Oncology, Inc. CLVS Stock Holding History

EcoR1 Capital’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-25,765
Closed -$2.12M – 50
2017
Q3 		$2.12M Buy
25,765
+15,765
+158% +$1.25M 0.28% 31
2017
Q2 		$936K Buy
+10,000
New +$612K 0.17% 33
2015
Q2 		– Sell
-243,048
Closed -$18M – 29
2015
Q1 		$18M Sell
243,048
-141,300
-37% -$9.98M 6.01% 7
2014
Q4 		$21.5M Buy
+384,348
New +$20.2M 10.89% 2

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

EcoR1 Capital's CLVS Position: Q4 2017 in Review

EcoR1 Capital sold out of Clovis Oncology, Inc. (CLVS) in Q4 2017, closing a stake of 25,765 shares — an estimated $2.12M sold.

EcoR1 Capital first reported a position in CLVS in Q4 2014 and held it in 4 quarters. The position peaked at $21.5M in Q4 2014. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

  • EcoR1 Capital reported no remaining Clovis Oncology, Inc. position as of Q4 2017 after selling out during the quarter.
  • EcoR1 Capital sold 25,765 Clovis Oncology, Inc. shares in Q4 2017, an estimated $2.12M.
  • EcoR1 Capital first reported a position in Clovis Oncology, Inc. in Q4 2014 and held it in 4 quarters.
  • EcoR1 Capital's Clovis Oncology, Inc. position peaked at $21.5M in Q4 2014.
  • 247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on EcoR1 Capital's 13F filing for Q4 2017, filed 14 Feb 2018.